1250-1252 Prevalence of mupirocin resistance in staphylococcus pseudintermedius

24Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the United States, veterinary use of mupirocin is primarily limited to the treatment of canine pyoderma caused by methicillin-resistant Staphylococcus pseudintermedius (MRSP). In this study, only 1 of 581 S. pseudintermedius isolates tested was resistant to mupirocin and carried the high-level mupirocin resistance gene, ileS2, on a plasmid. Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Godbeer, S. M., Gold, R. M., & Lawhon, S. D. (2014). 1250-1252 Prevalence of mupirocin resistance in staphylococcus pseudintermedius. Journal of Clinical Microbiology, 52(4), 1250–1252. https://doi.org/10.1128/JCM.03618-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free